Grace Therapeutics, Inc. (GRCE) — Capital Reinvestment Ratio
Latest as of December 2012:
0.59x
Grace Therapeutics, Inc. (GRCE) has a Capital Reinvestment Ratio of 0.59x as of December 2012, meaning it reinvests 1% of its operating cash flow ($136.29K) in capital expenditures ($80.55K). See Grace Therapeutics, Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.59x
Capex / Operating Cash Flow
Operating Cash Flow
$136.29K
USD
Capital Expenditures
$80.55K
USD
Data as of
Dec 2012
Most recent filing
Annual Capital Reinvestment Ratio for Grace Therapeutics, Inc. (None–None)
Year-by-year Capital Reinvestment Ratio for Grace Therapeutics, Inc. from None to None. For live market cap and broader valuation context, see GRCE stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow